Product
Help
Pricing
About
Jobs
Log in
Get started
Concept
Add to collection
Entry inhibitor
OpenAlex ID:
C2776997796
Maraviroc (UK-427,857), a Potent, Orally Bioavailable, and Selective Small-Molecule Inhibitor of Chemokine Receptor CCR5 with Broad-Spectrum Anti-Human Immunodeficiency Virus Type 1 Activity
2005
·
Patrick Dorr
, Mike Westby
, et al.
·
Antimicrobial Agents and Chemotherapy
·
1,324
Structure of the CCR5 Chemokine Receptor–HIV Entry Inhibitor Maraviroc Complex
2013
·
Qiuxiang Tan
, Ya Zhu
, et al.
·
Science
·
780
Discovery of cyanovirin-N, a novel human immunodeficiency virus-inactivating protein that binds viral surface envelope glycoprotein gp120: potential applications to microbicide development
1997
·
M R Boyd
, K R Gustafson
, et al.
·
Antimicrobial Agents and Chemotherapy
·
664
Small Molecules Blocking the Entry of Severe Acute Respiratory Syndrome Coronavirus into Host Cells
2004
·
Ling Yi
, Zhengquan Li
, et al.
·
Journal of Virology
·
509
High concentrations of recombinant soluble CD4 are required to neutralize primary human immunodeficiency virus type 1 isolates.
1990
·
E S Daar
, X L Li
, et al.
·
Proceedings of the National Academy of Sciences
·
478
Isolation and Characterization of Griffithsin, a Novel HIV-inactivating Protein, from the Red Alga Griffithsia sp.
2004
·
Toshiyuki Mori
, Barry R. O'Keefe
, et al.
·
Journal of Biological Chemistry
·
477
A binding pocket for a small molecule inhibitor of HIV-1 entry within the transmembrane helices of CCR5
2000
·
Tatjana Dragic
, Alexandra Trkola
, et al.
·
Proceedings of the National Academy of Sciences
·
477
The HIV Env-mediated fusion reaction
2003
·
Stephen A. Gallo
, Catherine M. Finnegan
, et al.
·
Biochimica et Biophysica Acta (BBA) - Biomembranes
·
472
PDF
A Synthetic Peptide from HIV-1 gp41 Is a Potent Inhibitor of Virus-Mediated Cell—Cell Fusion
1993
·
Carl Wild
, Teresa Greenwell
, et al.
·
AIDS Research and Human Retroviruses
·
429
Protein Design of an HIV-1 Entry Inhibitor
2001
·
Michael J. Root
, Michael S. Kay
, et al.
·
Science
·
423
Subgroup Analyses of Maraviroc in Previously Treated R5 HIV-1 Infection
2008
·
Gerd Fätkenheuer
, Mark Nelson
, et al.
·
New England Journal of Medicine
·
389
A small molecule HIV-1 inhibitor that targets the HIV-1 envelope and inhibits CD4 receptor binding
2003
·
Pin-Fang Lin
, Wade Blair
, et al.
·
Proceedings of the National Academy of Sciences
·
382
Reduced Maximal Inhibition in Phenotypic Susceptibility Assays Indicates that Viral Strains Resistant to the CCR5 Antagonist Maraviroc Utilize Inhibitor-Bound Receptor for Entry
2006
·
Mike Westby
, Caroline Smith-Burchnell
, et al.
·
Journal of Virology
·
380
HIV entry inhibitors
2007
·
José A Esté
, Amalio Telenti
·
The Lancet
·
367
HIV-1 escape from a small molecule, CCR5-specific entry inhibitor does not involve CXCR4 use
2002
·
Alexandra Trkola
, Shawn E. Kuhmann
, et al.
·
Proceedings of the National Academy of Sciences
·
320
SCH-C (SCH 351125), an orally bioavailable, small molecule antagonist of the chemokine receptor CCR5, is a potent inhibitor of HIV-1 infection in vitro and in vivo
2001
·
Julie M. Strizki
, Serena Xu
, et al.
·
Proceedings of the National Academy of Sciences
·
314
Virions of primary human immunodeficiency virus type 1 isolates resistant to soluble CD4 (sCD4) neutralization differ in sCD4 binding and glycoprotein gp120 retention from sCD4-sensitive isolates
1992
·
J P Moore
, J A McKeating
, et al.
·
Journal of Virology
·
302
High Density Lipoproteins Facilitate Hepatitis C Virus Entry through the Scavenger Receptor Class B Type I
2005
·
Cécile Voisset
, Nathalie Callens
, et al.
·
Journal of Biological Chemistry
·
292
PDF
Discovery and Optimization of a Natural HIV-1 Entry Inhibitor Targeting the gp41 Fusion Peptide
2007
·
Jan Münch
, Ludger Ständker
, et al.
·
Cell
·
289
PDF
Design of potent inhibitors of HIV-1 entry from the gp41 N-peptide region
2001
·
Debra M. Eckert
, Peter S. Kim
·
Proceedings of the National Academy of Sciences
·
285
Scaleable manufacture of HIV-1 entry inhibitor griffithsin and validation of its safety and efficacy as a topical microbicide component
2009
·
Barry R. O'Keefe
, Fakhrieh Vojdani
, et al.
·
Proceedings of the National Academy of Sciences
·
281
N-Substituted Pyrrole Derivatives as Novel Human Immunodeficiency Virus Type 1 Entry Inhibitors That Interfere with the gp41 Six-Helix Bundle Formation and Block Virus Fusion
2004
·
Shibo Jiang
, Hong Lu
, et al.
·
Antimicrobial Agents and Chemotherapy
·
271
Cyclosporin A inhibits hepatitis B and hepatitis D virus entry by cyclophilin-independent interference with the NTCP receptor
2013
·
Shirin Nkongolo
, Yi Ni
, et al.
·
Journal of Hepatology
·
269
Molecular Mechanisms of HIV Entry
2011
·
Craig B. Wilen
, John C. Tilton
, et al.
·
Advances in experimental medicine and biology
·
256
Entry inhibitors in the treatment of HIV-1 infection
2009
·
John C. Tilton
, Robert W. Doms
·
Antiviral Research
·
252
Show more works
View as search
Works count:
734
Citation count:
33,410
Year
Topic
Type